People with depression and anxiety may be at greater risk of developing Alzheimer's disease earlier than those without the conditions. On average, people with depression developed Alzheimer's symptoms two years earlier, and those with anxiety three years earlier, than those who did not suffer from the mental health disorders. Read More
Migraine sufferers who embarked on two-and-a-half hours of moderate to vigorous exercise per week reported a significant decline in their migraine triggers, including stress, depression, and sleep problems. Read More
51% of COVID-19 patients report they experienced the loss of smell and taste up to five months after infection. On average, once their senses were restored, people reported a loss in sensitivity to smell and taste. Read More
Study reveals those with frontotemporal dementia have greater white matter hyperintensity than those with other forms of dementia. The amount of white matter hyperintensity was associated with the severity of FTD symptoms. Read More
Contrary to popular belief, women with multiple sclerosis may not be at higher risk for complications during pregnancy, such as gestational diabetes or still-birth. However, babies of mothers with MS are more likely to be induced or believed by elective C-sections. Read More
Enlarged perivascular spaces around small blood vessels in the brain may be a biomarker for cognitive decline, and ultimately dementia, a new study reports. Read More
While 40% of people with primary progressive aphasia have underlying Alzheimer's disease, a new study suggests they may not develop the memory problems associated with Alzheimer's. Read More
For carriers of the Parkinson's related LRRK2 gene, coffee consumption can help lower the risk of developing symptoms of the disease. Read More
Researchers identified five unapproved drugs in dangerous combinations and doses in over-the-counter cognitive enhancement drugs. Side effects of the unapproved drugs include increases and decreases in blood pressure, agitation, and sedation. Read More
A genetic variation that alters the metabolism of glutathione may be responsible for cognitive decline in people who do not have other associated biomarkers, a new study reports. Read More
Anticholinergic medications, commonly used for conditions including allergies, high blood pressure, Parkinson's disease, and motion sickness, have been linked to an increased risk of cognitive decline and memory problems, especially in those with genetic risk factors for Alzheimer's disease. Read More
Eating a diet rich in vegetables and nuts during middle age is linked to fewer symptoms that may precede Parkinson's disease. Read More